Skip to content
DraconiticResearch
Search Sources API
223,238 studies31 sourcesUpdated 21 min ago
Peer-reviewedCC BY-NC 4.0Vox Sanguinis

Mapping syphilis surveillance: Insights into blood donation screening practices worldwide

  • Michel‐Andrés García‐Otálora1
  • Guillermo Orjuela‐Falla2
  • Carl P. McDonald3
  • Sandra Ramirez‐Arcos4,5,6
  • ISBT Transfusion‐Transmitted Infectious Diseases Working Party Subgroup on Bacteria
6 affiliations
  1. 1School of Medicine and Health Science, Public Health Research Group Universidad del Rosario Bogotá Colombia
  2. 2Scientific Affairs, Transfusion Medicine Abbott Laboratories Bogotá Colombia
  3. 3National Health Service Blood and Transplant London UK
  4. 4Medical Microbiology Canadian Blood Services Ottawa Ontario Canada
  5. 5Surveillance and Discovery Laboratory Canadian Blood Services Ottawa Ontario Canada
  6. 6Department of Biochemistry, Microbiology and Immunology University of Ottawa Ottawa Ontario Canada
Read full textDOICite

Abstract

Background and Objectives: Syphilis is caused by the bacterial spirochete Treponema pallidum and can be transmitted through blood transfusion. However, there have been less than 10 documented transfusion‐transmitted cases since World War II. Global data comparing population‐level syphilis trends with blood donor reactivity and screening practices are limited. This study aimed to compare syphilis screening practices worldwide and to explore the value of universal donor screening.

Materials and Methods: A cross‐sectional international survey was conducted among blood transfusion professionals. Participants reported data collected between 2018 and 2024 on syphilis prevalence, blood donor screening algorithms and reactivity rates, deferral policies and blood safety interventions. Descriptive analyses were performed by year and geographic region.

Results: Thirty‐nine participants from 26 countries across five continents answered the survey. Universal donor screening was reported by 35 of 36 institutions providing policy data, with treponemal assays representing the predominant screening approach. Substantial variation was observed in confirmatory testing, donor deferral criteria and donor re‐entry policies. Reactivity rates varied markedly across centres and were higher among first‐time donors compared to repeat donors. Institutions with higher syphilis rates generally reported higher donor reactivity. Routine leukoreduction was reported by 66.7% of institutions, while pathogen reduction technologies were routinely used by 36.1%. Most centres apply indefinite donor deferral and have not considered removing screening.

Conclusion: Syphilis screening and donor management practices vary across blood services worldwide despite widespread implementation of universal screening. Local epidemiology, testing strategies and donor eligibility policies contribute to observed differences in donor reactivity and surveillance practices.

Related

  1. 2022 WHO estimates for overall and human papillomavirus test-based cervical cancer screening coverage worldwide: a review and synthetic analysis
    Beatriz Serrano, Esther Roura, Laia Alemany +10
    The Lancet Global HealthPeer-reviewedCC BY-NC-ND 3.0-IGOEpidemiology & public healthCrossref
  2. Prevalence of screening markers for HIV, hepatitis B virus, hepatitis C virus, and syphilis and associated factors among voluntary non-remunerated blood donors in Addis Ababa, Ethiopia: a cross-sectional study
    Muluken Kassahun Geremew, Mulugeta Shegaze Shimbre, Ashenafi Tazebew Amare +1
    BMC Public HealthPeer-reviewedCC BY 4.0Epidemiology & public healthCrossref
  3. Dissemination of ESBL-producing Escherichia coli and carriage in the community worldwide: epidemiology, transmission pathways, molecular insights, and practical aspects
    Anne‐Lise Beaumont, Maxime Danjean, Hervé Jacquier +5
    Clinical Microbiology ReviewsPeer-reviewedLicence not stated6 citedGeneral medicineOpenAlex
  4. Epidemiologic trends of syphilis in Qatar 2015-2024: A decade of surveillance data
    Aseel H. Alzibdeh, Joanne Daghfal, Bashir Ali +4
    IJID RegionsPeer-reviewedCC BY-NC-ND 4.0Full textInfectious diseasePMC
  5. Syphilis, Gonorrhea, and Chlamydia Notifications in Galați County, Romania (2017-2025): A Retrospective Surveillance Analysis.
    Ionelia State, Laura Cristescu-Budală, Rares-Nicolae Vadana +3
    Diseases (Basel, Switzerland)Peer-reviewedCC BYFull textPhysiologyEurope PMC

Cite

BibTeXRIS
BibTeX
@article{garciaotalora2026mapping,
  title = {{Mapping syphilis surveillance: Insights into blood donation screening practices worldwide}},
  author = {Michel‐Andrés García‐Otálora and Guillermo Orjuela‐Falla and Carl P. McDonald and Sandra Ramirez‐Arcos and ISBT Transfusion‐Transmitted Infectious Diseases Working Party Subgroup on Bacteria},
  journal = {Vox Sanguinis},
  year = {2026},
  month = aug,
  doi = {10.1111/vox.70335},
  url = {https://doi.org/10.1111/vox.70335},
  note = {CC BY-NC 4.0},
}
RIS
TY  - JOUR
TI  - Mapping syphilis surveillance: Insights into blood donation screening practices worldwide
AU  - Michel‐Andrés García‐Otálora
AU  - Guillermo Orjuela‐Falla
AU  - Carl P. McDonald
AU  - Sandra Ramirez‐Arcos
AU  - ISBT Transfusion‐Transmitted Infectious Diseases Working Party Subgroup on Bacteria
PY  - 2026
DA  - 2026/08/09
JO  - Vox Sanguinis
DO  - 10.1111/vox.70335
UR  - https://doi.org/10.1111/vox.70335
AB  - Background and Objectives: Syphilis is caused by the bacterial spirochete Treponema pallidum and can be transmitted through blood transfusion. However, there have been less than 10 documented transfusion‐transmitted cases since World War II. Global data comparing population‐level syphilis trends with blood donor reactivity and screening practices are limited. This study aimed to compare syphilis screening practices worldwide and to explore the value of universal donor screening.  Materials and Methods: A cross‐sectional international survey was conducted among blood transfusion professionals. Participants reported data collected between 2018 and 2024 on syphilis prevalence, blood donor screening algorithms and reactivity rates, deferral policies and blood safety interventions. Descriptive analyses were performed by year and geographic region.  Results: Thirty‐nine participants from 26 countries across five continents answered the survey. Universal donor screening was reported by 35 of 36 institutions providing policy data, with treponemal assays representing the predominant screening approach. Substantial variation was observed in confirmatory testing, donor deferral criteria and donor re‐entry policies. Reactivity rates varied markedly across centres and were higher among first‐time donors compared to repeat donors. Institutions with higher syphilis rates generally reported higher donor reactivity. Routine leukoreduction was reported by 66.7% of institutions, while pathogen reduction technologies were routinely used by 36.1%. Most centres apply indefinite donor deferral and have not considered removing screening.  Conclusion: Syphilis screening and donor management practices vary across blood services worldwide despite widespread implementation of universal screening. Local epidemiology, testing strategies and donor eligibility policies contribute to observed differences in donor reactivity and surveillance practices.
SN  - 0042-9007
SN  - 1423-0410
ER  -